학술논문

Variation in the expression level of MALAT1, MIAT and XIST lncRNAs in coronary artery disease patients with and without type 2 diabetes mellitus.
Document Type
Article
Source
Archives of Physiology & Biochemistry. Oct2022, Vol. 128 Issue 5, p1308-1315. 8p.
Subject
*TYPE 2 diabetes
*LINCRNA
*CORONARY artery disease
*GLYCEMIC control
Language
ISSN
1381-3455
Abstract
Background: The MALAT1, MIAT, and XIST long noncoding RNAs (lncRNAs) participate in the pathogenesis of complex diseases and also serve as diagnostic markers. The study aimed to assess their expressions in CAD patients with or without T2DM against diabetic and non-diabetic controls. Methods: The expression levels of three lncRNAs in 50 CAD patients (with or without diabetes) and 50 non-CAD subjects (with or without diabetes) were evaluated by using the TaqMan Assay method. Results: MALAT1 and MIAT were upregulated in CAD patients (p Value=.0008 and.0078, respectively). The expression level of XIST was significantly elevated diabetic compared to non-diabetic CAD patients (p Value=.0003). MALAT1 gene had the highest diagnostic power for discrimination of CAD patients from controls (AUC= 0.682, p Value=.001). Conclusions: The current study supports the participation of lncRNAs in the pathogenesis of CAD and T2DM and highlights their potential as diagnostic biomarkers. [ABSTRACT FROM AUTHOR]